Altacor Ltd
CAMBRIDGE, England, July 26, 2011 -
Altacor has gained exclusive worldwide rights from Ophthalmopharma for their two proprietary therapeutic development products Latanoprost CD and Cyclosporin A Prodrug.
CAMBRIDGE, England, April 21, 2011 - Altacor announces that it has today concluded an exclusive,
worldwide licensing agreement with the Swiss based company Ophthalmopharma
for its proprietary, preloaded injector for delivery of intraocular lens in
cataract and corrective lens replacement surgery (currently known as
SOLO(R)).
CAMBRIDGE, England, April 21, 2011 - Altacor has concluded an exclusive worldwide licensing
agreement with Ophthalmopharma for the Age Related Macular Degeneration (AMD)
nutritional product EYEBAR(R).
CAMBRIDGE, England, February 8, 2011 - Altacor today announced the closing of the second tranche
(GBP1.9m) of a GBP3.4m equity fund raising which was led by Clive Austin of
NVM Private Equity and included Enterprise Ventures (through its RisingStars
Growth Fund) and Beringea, an existing investor.
CAMBRIDGE, England - Ophthalmology development and marketing company Altacor has announced closing of a GBP1m first tranche of Series B funding.
